Tarceva (erlotinib) in combination with gemcitabine is indicated for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

This section is intended to help you when considering treatment options such as Tarceva (erlotinib) for advanced pancreatic cancer.

About Tarceva

Here you'll find a general description of Tarceva and its design as a targeted treatment.

Pancreatic Cancer Treatment with Tarceva

Learn how Tarceva in combination with gemcitabine works to disrupt cancer cell activities.

Possible Benefits of Tarceva

Tarceva is convenient to use and, based on a recent large clinical study, helped a broad range of patients live longer.

Preparing to Meet with Your Doctor

Answer some questions to help determine if you are a candidate for Tarceva, and find a printable list of useful questions to ask your physician.

Tarceva Clinical Trial Information

Learn about cancer treatment studies, the different types of clinical trials, and how the key trial of Tarceva was conducted. Also get useful information if you're interested in participating in a study.